Literature DB >> 12732234

A secretin i.v. infusion activates gene expression in the central amygdala of rats.

M Goulet1, P J Shiromani, C M Ware, R A Strong, R Boismenu, J R Rusche.   

Abstract

For the last 100 years secretin has been extensively studied for its hormonal effects on digestion. Recent observations that the deficits in social reciprocity skills seen in young (3-4-year-old) autistic children are improved after secretin infusions suggest an additional influence on neuronal activity. We show here that i.v. administration of secretin in rats induces Fos protein expression in the neurons of the central amygdala as well as the area postrema, bed nucleus of the stria terminalis, external lateral parabrachial nucleus and supraoptic nucleus. However, secretin infusion did not induce Fos expression in the solitary tract nucleus or paraventricular nucleus, regions normally activated by related peptides such as cholecystokinin. The peak blood levels of secretin that induce Fos protein expression in rat brain are similar to the peak blood levels observed during i.v. treatment with secretin in humans. The amygdala is known to be critical for developing reciprocal social interaction skills and abnormalities in this brain region have been demonstrated in autistic children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732234     DOI: 10.1016/s0306-4522(02)00782-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

Review 1.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 2.  Distribution and Functional Implication of Secretin in Multiple Brain Regions.

Authors:  Ruanna Wang; Billy K C Chow; Li Zhang
Journal:  J Mol Neurosci       Date:  2018-06-07       Impact factor: 3.444

3.  Secretin mRNA in the subdivision of primary sensory neurons in the trigeminal ganglion of rats.

Authors:  Andrea Heinzlmann; Zsuzsanna E Tóth; Katalin Köves
Journal:  J Mol Neurosci       Date:  2010-06-26       Impact factor: 3.444

Review 4.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  Secretin attenuates the hereditary repetitive hyperactive movements in a mouse model.

Authors:  Katalin Köves; Gusztav Kiss; Andrea Heinzlmann; Roberta Dochnal; M Manczinger; Agnes Pál; I Sípos; Gyula Szabó
Journal:  J Mol Neurosci       Date:  2010-07-06       Impact factor: 3.444

6.  Intranasal application of secretin, similarly to intracerebroventricular administration, influences the motor behavior of mice probably through specific receptors.

Authors:  Andrea Heinzlmann; Gusztáv Kiss; Zsuzsanna E Tóth; Roberta Dochnal; Ágnes Pál; Ildikó Sipos; Máté Manczinger; Gyula Szabó; Hitoshi Hashimoto; Katalin Köves
Journal:  J Mol Neurosci       Date:  2012-07-01       Impact factor: 3.444

7.  Distribution of secretin receptors in the rat central nervous system: an in situ hybridization study.

Authors:  Zsuzsanna E Tóth; Andrea Heinzlmann; Hitoshi Hashimoto; Katalin Köves
Journal:  J Mol Neurosci       Date:  2012-10-11       Impact factor: 3.444

8.  Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism.

Authors:  M G Welch; J D Keune; T B Welch-Horan; N Anwar; M Anwar; R J Ludwig; D A Ruggiero
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

9.  Inhibition of fear potentiated startle in rats following peripheral administration of secretin.

Authors:  Karyn Myers; Martin Goulet; James Rusche; Richard Boismenu; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2003-10-29       Impact factor: 4.530

Review 10.  The role of secretin in the cerebellum.

Authors:  Wing-Ho Yung; Ying-Shing Chan; Billy K C Chow; Jian-Jun Wang
Journal:  Cerebellum       Date:  2006       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.